Evidence map›Paper›PMID 39215003›Full record

ArticleNature communications2024

scCAD: Cluster decomposition-based anomaly detection for rare cell identification in single-cell expression data.

Yunpei Xu, Shaokai Wang, Qilong Feng, Jiazhi Xia, Yaohang Li, Hong-Dong Li, Jianxin Wang

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yunpei Xu *School of Computer Science and Engineering, Central South University, Changsha, China.
Shaokai Wang *David R. Cheriton School of Computer Science, University of Waterloo, Waterloo, ON, Canada.
Qilong FengSchool of Computer Science and Engineering, Central South University, Changsha, China.
Jiazhi XiaSchool of Computer Science and Engineering, Central South University, Changsha, China.
Yaohang LiDepartment of Computer Science, Old Dominion University, Norfolk, VA, USA.ORCID 0000-0003-0178-1876
Hong-Dong LiSchool of Computer Science and Engineering, Central South University, Changsha, China. hongdong@csu.edu.cn.ORCID 0000-0003-3438-739X
Jianxin WangSchool of Computer Science and Engineering, Central South University, Changsha, China. jxwang@mail.csu.edu.cn.ORCID 0000-0003-1516-0480

Funding

National Natural Science Foundation of China (National Science Foundation of China) 62150048
6 · The paper itself

Abstract

Single-cell RNA sequencing (scRNA-seq) technologies have become essential tools for characterizing cellular landscapes within complex tissues. Large-scale single-cell transcriptomics holds great potential for identifying rare cell types critical to the pathogenesis of diseases and biological processes. Existing methods for identifying rare cell types often rely on one-time clustering using partial or global gene expression. However, these rare cell types may be overlooked during the clustering phase, posing challenges for their accurate identification. In this paper, we propose a Cluster decomposition-based Anomaly Detection method (scCAD), which iteratively decomposes clusters based on the most differential signals in each cluster to effectively separate rare cell types and achieve accurate identification. We benchmark scCAD on 25 real-world scRNA-seq datasets, demonstrating its superior performance compared to 10 state-of-the-art methods. In-depth case studies across diverse datasets, including mouse airway, brain, intestine, human pancreas, immunology data, and clear cell renal cell carcinoma, showcase scCAD's efficiency in identifying rare cell types in complex biological scenarios. Furthermore, scCAD can correct the annotation of rare cell types and identify immune cell subtypes associated with disease, thereby offering valuable insights into disease progression.

Indexed as

Single-Cell AnalysisAlgorithmsAnimalsCluster AnalysisComputational BiologyGene Expression ProfilingHumansMicePancreasRNA-SeqSequence Analysis, RNATranscriptome

Identifiers

PMID39215003
PMCPMC11364754

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.